Skip to main content

Table 2 Univariate analysis of survival time by categorical variable

From: Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis

Parameter

Log-rank

Test value

Degrees of Freedom

P

Gender

1,79

1

0,1811

Age (years)

0,34

1

0,5586

PS

229,07

4

<0.001

Location

10,60

2

<0.005

Grading

15,22

2

<0.005

Primary tumor extent

40,90

3

<0.001

Distant Metastasis

38,80

1

<0.001

Ploidy-group

93,79

2

<0.001

Epoetin

9,16

1

0.003

Blood Transfusion

22,64

1

<0.001

Weight loss

178,78

3

<0.001

Pain

79,81

3

<0.001

Jaundice

6,49

1

0.01

Thrombophlebitis

16,87

1

<0.001

Diabetes

4,36

1

0.04

Steatorrhoea

37,96

1

<0.001

CEA

37,51

1

0.001

CA 199

1,13

1

<0.001

Amylase

6,43

1

0.01

CRP

6,95

2

0.03

Albumin

54,78

1

<0.001

Therapy

161,48

3

<0.001

  1. PS: Performance Status; CEA, carcinoembryonic antigen; CA 19-9, cancer antigen 19-9; CRP, C-reactive protein.